Your session is about to expire
← Back to Search
Low-Dose Fatty Acids for Insulin Resistance (BCAA Trial)
BCAA Trial Summary
This trial is testing whether a low dose of fatty acids can cause mild insulin resistance in healthy volunteers, in order to select a dose for future studies.
BCAA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 2 & 3 trial • 100 Patients • NCT00672854BCAA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of diabetes.You are allergic to metal, specifically aluminum.More than one of my immediate family members has diabetes.My hemoglobin level is below the normal range for my gender.My cholesterol or triglycerides levels are high.You are currently struggling with alcohol or drug abuse.I am allergic to soy or eggs.I am on long-term steroids but take ≤ 5 mg of prednisone daily or its equivalent.I have severe heart issues, including a recent heart attack or poor heart function.Your liver function tests have been consistently higher than normal.Your HbA1c level is higher than 5.7%.I have had pancreatitis before.My kidney function is reduced, with an eGFR below 55 ml/min/1.73 m2.I have a seizure disorder.Your body mass index (BMI) is either too low (less than 19) or too high (more than 27).I am not pregnant, breastfeeding, and I agree to use effective birth control during the study.You have used tobacco in the past year.Your blood pressure is higher than 160 over 100.
- Group 1: Low Dose Fatty Acids
- Group 2: Medium Dose Fatty Acids
- Group 3: Saline
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there currently an open call for participants in this research?
"The clinical trial is still recruiting, as per information on the website of clinicaltrials.gov. The study was inaugurated January 1st 2020 and has been modified most recently on August 1 2022."
How many individuals have been enlisted for this clinical investigation?
"Affirmative. Clinicaltrials.gov's information demonstrates that this study is currently recruiting participants, with a commencement date of January 1st 2020 and last edit on August 1st 2022. 12 individuals are needed between the single site for inclusion in the trial."
Am I eligible for involvement in this medical experiment?
"This research is targeting 12 individuals aged 18 to 39, who display signs of insulin resistance. Those interested must be able to understand and agree with the study's protocol in writing."
What medical conditions can be addressed through Intralipid, 20% Intravenous Emulsion treatment?
"Intravenous Emulsion, 20% can be administered to rectify nutritional deficits caused by parenteral nutrition and ascorbic acid deficiency."
Does this clinical experiment include adults aged 18 and above?
"This clinical trial is only open to those aged 18-39. Furthermore, there are 72 trials specifically for minors and 758 studies targeting patients over 65 years old."
What further research has been done into the effects of Intralipid, 20% Intravenous Emulsion?
"Presently, there are 13 clinical trials dedicated to Intralipid, 20% Intravenous Emulsion. Three of these live studies have advanced to Phase 3 testing. Despite the majority taking place in Boston, Massachusetts, 27 centres across the US are running investigations on this drug's efficacy."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger